2019
8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)
Publication
Publication
Journal of Hepatology , Volume 70 - Issue 3 p. 554- 557
Additional Metadata | |
---|---|
doi.org/10.1016/j.jhep.2018.10.032, hdl.handle.net/1765/115183 | |
Journal of Hepatology | |
Organisation | Department of Internal Medicine |
Boerekamps, A., Vanwolleghem, T., van der Valk, M, van den Berk, G.E., van Kasteren, M, Posthouwer, D., … Rijnders, B. (2019). 8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study). Journal of Hepatology, 70(3), 554–557. doi:10.1016/j.jhep.2018.10.032 |